文献速递前列腺癌

区域人群PSA信息与检测项目5年结局

The 5-year outcomes of a regional population-based PSA information and testing programme.
PubMed 文献 · BJU Int · 2026-02-18

平均20%受告知男性6个月内检测PSA,0.8%确诊前列腺癌,低中危肿瘤增加,提示需警惕过度检出。

要点

  • 邮寄PSA信息结合基层可及检测在区域层面可行,受告知男性参与率较高。
  • 受告知男性中0.8%确诊前列腺癌,主要为中低危肿瘤增加。
  • 低危肿瘤增加提示需优化筛查策略与诊断流程以避免过度检出。

核心结论

  • 组织区域性邮寄PSA信息项目并结合基层可及检测在斯堪的纳维亚医疗环境中可行且参与率较高。
  • 观察到低危肿瘤增加,提示应谨慎实施项目并重视设计良好的筛查策略与诊断算法以避免过度检出。

研究设计与样本

  • 受告知男性若希望检测则联系初级保健中心,PSA≥3 μg/L者转诊泌尿科评估。
  • 利用地方和国家登记数据报告项目实施后PSA检测、诊断活动与诊断结局的趋势。

主要发现

  • 平均20%的受告知男性在6个月内接受了PSA检测,且比例随时间增加。
  • 受告知男性中3.5% PSA≥3 μg/L,3.6%接受泌尿科咨询,1.5%接受活检,0.8%确诊前列腺癌。
  • 接受磁共振成像的比例较低。
  • 50-74岁年龄组年前列腺癌发病率从386(2010-2013)增至659例/10万(2016-2019),增加主要见于中危和低危肿瘤。

临床怎么用

  • 区域邮寄PSA信息结合基层检测可作为前列腺癌早期发现的组织方式,但需配套避免过度检出的诊断流程。
  • 对PSA≥3 μg/L者转诊泌尿科评估的路径在项目中可行。
  • 应关注低危肿瘤检出增加,审慎设计筛查策略与诊断算法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To report descriptive outcomes including prostate-specific antigen (PSA) testing, diagnostic activity and diagnostic outcomes during the initial 5 years of a regional mailed PSA information and testing programme. SUBJECTS AND METHODS: Between 2015 and 2019 a letter regarding the pros and cons of PSA testing was sent to all men in the Värmland region of Sweden in every fifth year age group between 50 and 70 years. A total of 44 530 men were informed and instructed to contact their primary care centre if they wished to have a PSA test. Men with a PSA level ≥3 μg/L were referred to a urologist for evaluation. We used local and national registers to report trends in PSA testing, diagnostic activity, and diagnostic outcomes after programme implementation. RESULTS: An average of 20% of informed men had a PSA test within 6 months, with increasing proportions over time. Among informed men, 3.5% had a PSA level ≥3 μg/L, 3.6% had a urology consultation, 1.5% underwent biopsies, and 0.8% were diagnosed with prostate cancer. [Correction added on 26 February 2026, after first online publication: The word 'tested' has been corrected to 'informed' in the preceding sentence.] The proportion who underwent magnetic resonance imaging was low. Between 2014 and 2017, the yearly number of PSA-tested men in the region increased from 4800 to 11 800 and the number of men undergoing prostate biopsies increased from 772 to 1217. Yearly prostate cancer incidence in the age group 50-74 years increased from 386 (2010-2013) to 659 cases/100 000 (2016-2019). We observed an increase mainly among intermediate- and low-risk tumours. At the end of the period, 80% of men in the older-age groups had had a PSA test during the preceding years. CONCLUSIONS: Organising a population-based mailed PSA information programme combined with accessible testing in primary care is feasible on a regional scale in a Scandinavian healthcare setting and may reach high attendance. An observed increase in low-risk tumours inspires caution against programme implementation and highlights the importance of well-designed screening strategies and diagnostic algorithms to avoid over-detection.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Ugge H, Daouacher G, Waldén M, et al. The 5-year outcomes of a regional population-based PSA information and testing programme. BJU Int. 2026. PMID: 41705716. doi:10.1111/bju.70180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。